103 related articles for article (PubMed ID: 28415789)
1. Hmga2 translocation induced in skin tumorigenesis.
Li Y; Pi XY; Boland K; Lad S; Johnson K; Verfaillie C; Morris RJ
Oncotarget; 2017 May; 8(18):30019-30029. PubMed ID: 28415789
[TBL] [Abstract][Full Text] [Related]
2. Biomarker function of HMGA2 in ultraviolet-induced skin cancer development.
Ha W; Hinde A; Xie L; Trager MH; Liu L
Exp Dermatol; 2020 Oct; 29(10):1021-1026. PubMed ID: 32780494
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines.
Di Fazio P; Montalbano R; Neureiter D; Alinger B; Schmidt A; Merkel AL; Quint K; Ocker M
Exp Cell Res; 2012 Sep; 318(15):1832-43. PubMed ID: 22683924
[TBL] [Abstract][Full Text] [Related]
4. RAS induced senescence of skin keratinocytes is mediated through Rho-associated protein kinase (ROCK).
Lee AJ; Fraser E; Flowers B; Kim J; Wong K; Cataisson C; Liu H; Yang H; Lee MP; Yuspa SH; Li L
Mol Carcinog; 2021 Dec; 60(12):799-812. PubMed ID: 34534377
[TBL] [Abstract][Full Text] [Related]
5. High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia.
Unachukwu U; Chada K; D'Armiento J
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365712
[TBL] [Abstract][Full Text] [Related]
6. Hmga2 is dispensable for cutaneous squamous cell carcinoma.
White A; Flores A; Ong J; Lowry WE
Exp Dermatol; 2016 May; 25(5):409-12. PubMed ID: 26901496
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
[TBL] [Abstract][Full Text] [Related]
8. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.
Fedele M; Visone R; De Martino I; Troncone G; Palmieri D; Battista S; Ciarmiello A; Pallante P; Arra C; Melillo RM; Helin K; Croce CM; Fusco A
Cancer Cell; 2006 Jun; 9(6):459-71. PubMed ID: 16766265
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter in myeloproliferative neoplasms.
Harada-Shirado K; Ikeda K; Ogawa K; Ohkawara H; Kimura H; Kai T; Noji H; Morishita S; Komatsu N; Takeishi Y
Br J Haematol; 2015 Feb; 168(3):338-49. PubMed ID: 25236537
[TBL] [Abstract][Full Text] [Related]
10. PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.
Palmieri D; Valentino T; De Martino I; Esposito F; Cappabianca P; Wierinckx A; Vitiello M; Lombardi G; Colao A; Trouillas J; Pierantoni GM; Fusco A; Fedele M
Endocr Relat Cancer; 2012 Apr; 19(2):123-35. PubMed ID: 22199144
[TBL] [Abstract][Full Text] [Related]
11. TRIM71 suppresses tumorigenesis via modulation of Lin28B-let-7-HMGA2 signaling.
Yin J; Kim TH; Park N; Shin D; Choi HI; Cho S; Park JB; Kim JH
Oncotarget; 2016 Nov; 7(48):79854-79868. PubMed ID: 27821801
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2.
Tessari MA; Gostissa M; Altamura S; Sgarra R; Rustighi A; Salvagno C; Caretti G; Imbriano C; Mantovani R; Del Sal G; Giancotti V; Manfioletti G
Mol Cell Biol; 2003 Dec; 23(24):9104-16. PubMed ID: 14645522
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes.
Indra AK; Castaneda E; Antal MC; Jiang M; Messaddeq N; Meng X; Loehr CV; Gariglio P; Kato S; Wahli W; Desvergne B; Metzger D; Chambon P
J Invest Dermatol; 2007 May; 127(5):1250-60. PubMed ID: 17301838
[TBL] [Abstract][Full Text] [Related]
14. Suppression of skin tumorigenesis in CD109-deficient mice.
Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
[TBL] [Abstract][Full Text] [Related]
15. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
16. miR-195 Regulates Proliferation and Apoptosis through Inhibiting the mTOR/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells.
Li Y; Wu D; Wang P; Li X; Shi G
Dis Markers; 2017; 2017():8317913. PubMed ID: 28487599
[TBL] [Abstract][Full Text] [Related]
17. c-Fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesis.
Gebhardt C; Breitenbach U; Richter KH; Fürstenberger G; Mauch C; Angel P; Hess J
Am J Pathol; 2005 Jul; 167(1):243-53. PubMed ID: 15972968
[TBL] [Abstract][Full Text] [Related]
18. p14Arf acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis.
Markowski DN; Winter N; Meyer F; von Ahsen I; Wenk H; Nolte I; Bullerdiek J
Genes Chromosomes Cancer; 2011 Jul; 50(7):489-98. PubMed ID: 21456046
[TBL] [Abstract][Full Text] [Related]
19. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
20. HMGA2 participates in transformation in human lung cancer.
Di Cello F; Hillion J; Hristov A; Wood LJ; Mukherjee M; Schuldenfrei A; Kowalski J; Bhattacharya R; Ashfaq R; Resar LM
Mol Cancer Res; 2008 May; 6(5):743-50. PubMed ID: 18505920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
